PLYXPolaryx Therapeutics, Inc.

NASDAQ ยท Utilities ยท Large Cap ยท Mkt cap $41.3B ยท Vol 28.66M

$594.96

โ–ผ -3.58% today

Fetching live priceโ€ฆ

God's Eye forensics

Accounting quality and solvency screens. Anything that can't be computed from available filings data is left blank rather than estimated.

Piotroski F-Score

5/5

5

5 of 5 financial-health checks passed (4 checks need data this provider doesn't publish).

Altman Z-Score

Insufficient data

โ€”

Needs total assets, operating profit and debt โ€” not published for this listing yet.

Beneish (earnings quality)

Insufficient data

โ€”

The full manipulation model needs two years of receivables, depreciation and accrual data, which isn't published for this listing.

Scores are free. The criteria-by-criteria breakdown โ€” exactly which checks this company failed โ€” is part of DeepScreen Pro.

Fundamental breakdown โ€” raw ratios are free ยท fetching live data โ€” showing modeled estimates for now

P/E Ratio (TTM)

Modeled

11.2x

Cheap vs. earnings

Contextual insight โ€” DeepScreen Pro

PEG Ratio

Modeled

0.76

Undervalued vs. growth

Contextual insight โ€” DeepScreen Pro

P/S Ratio

Modeled

0.74x

Modest sales multiple

Contextual insight โ€” DeepScreen Pro

P/B Ratio

Modeled

2.98x

Reasonable

Contextual insight โ€” DeepScreen Pro

EV/Revenue

Modeled

1.05x

Low (value zone)

Contextual insight โ€” DeepScreen Pro

EV/EBITDA

Modeled

5.2x

Attractive

Contextual insight โ€” DeepScreen Pro

ROE

Modeled

26.6%

Excellent shareholder returns

Contextual insight โ€” DeepScreen Pro

ROA

Modeled

14.7%

Assets working hard

Contextual insight โ€” DeepScreen Pro

ROCE

Modeled

23.2%

High-quality compounder

Contextual insight โ€” DeepScreen Pro

Debt / Equity

Modeled

0.46x

Conservative balance sheet

Contextual insight โ€” DeepScreen Pro

LT Debt / Equity

Modeled

0.24x

Very low structural debt

Contextual insight โ€” DeepScreen Pro

Payout Ratio

Modeled

28%

Growth company โ€” reinvesting most profit

Contextual insight โ€” DeepScreen Pro

Operating Leverage

Modeled

2.60x

Profits amplify โ€” both ways

Contextual insight โ€” DeepScreen Pro

Company financials

EPS (TTM)
$53.12
Revenue (TTM)
$55.8B
Net margin
6.6%
EBITDA margin
20.2%
Earnings growth
14.7%
Dividend yield
2.5%
Payout ratio
28%
Debt / equity
0.46x

Live data hasn't loaded yet โ€” figures shown are DeepScreen's modeled estimates.

PLYX live news

LIVE

Loading live headlinesโ€ฆ